Jung‐Joo Choi

1.8k citations
41 papers · 1.5k indexed · h-index 24
Topics
Endometrial and Cervical Cancer Treatments (6 papers)Cancer-related molecular mechanisms research (5 papers)Ovarian cancer diagnosis and treatment (5 papers)

In The Last Decade

Jung‐Joo Choi

41 papers receiving 1.5k citations

Peers

Jung‐Joo Choi
Comparison fields: 5 of 96
  • Molecular Biology 830
  • Cancer Research 508
  • Immunology 386
  • Oncology 316
  • Epidemiology 191
Replace Hiroshi Ogawa with:
Hiroshi Ogawa Japan
Gwangil Kim South Korea
Cecilia S. Leung United States
Isabelle Matte Canada
Shengming Dai China
Junfen Xu China
Juan J. Roman United States
Hironori Tashiro Japan
Helena Stabile Italy
Magdalena Kowalewska Poland
Jung‐Joo Choi relative to Hiroshi Ogawa Japan Hiroshi Ogawa's profile →
Citations per field
00.5×1.5×2.2×
Hiroshi Ogawa · 1×
Citations per year

Countries citing papers authored by Jung‐Joo Choi

Since Specialization
Citations

This map shows the geographic impact of Jung‐Joo Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Joo Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Joo Choi more than expected).

Fields of papers citing papers by Jung‐Joo Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Joo Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Joo Choi. The network helps show where Jung‐Joo Choi may publish in the future.

Co-authorship network of co-authors of Jung‐Joo Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Joo Choi. A scholar is included among the top collaborators of Jung‐Joo Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Joo Choi. Jung‐Joo Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 2
4 11
5 3
6 56
7 46
8 37
9 68
10 23
11 16
12 3
13 31
14 268
15 66
16 44
17 56
18 30
19 35
20 32

About Jung‐Joo Choi

Jung‐Joo Choi is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 41 papers that have together received 1.5k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (6 papers), Cancer-related molecular mechanisms research (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). The work is most often cited by research in Cancer Research (508 citations), Reproductive Medicine (180 citations) and Immunology (386 citations). Jung‐Joo Choi has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Duk‐Soo Bae, Chel Hun Choi, Byoung‐Gie Kim, Tae‐Joong Kim, Jeong‐Won Lee, Je–Ho Lee, Young‐Jae Cho, Woo Young Kim, Sang Yong Song and Yoo-Young Lee. Their work appears in journals such as Biomaterials, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026